Interpretable models.
Dependable systems.

I’m Arman, a machine learning researcher and software engineer working on interpretable biomedical AI—from ECG signals to drug–target affinity.

Biomedical AI Interpretable ML Research engineering

Publication atlas4 published papers · 3 in 2026
2025—2026
01 / 04Scientific Reports · 2026
Drug + proteinInteract + residualAffinity estimate
Cold-start drug–target affinityHybrid multimodal model
02 / 04BioData Mining · 2026
ECG beatAngle + distanceClass / anomaly
ECG kernel learningAngle–distance representation
03 / 04Health Informatics Journal · 2026
Health indicatorsConcept structureRisk model
Interpretable heart-disease riskFCA-constrained logistic model
04 / 04SEEDA-CECNSM · 2025
Market sequenceForecast + CVaRAllocation
Risk-aware portfolio learningForecasting and sequential control
Choose a published paper to inspect

Drug and protein representations interact before simulated residual quantum paths return to classical fusion.

Partial pilot · state-vector simulation · no QPUExplore paper

ECG morphology is compared through angular similarity and distance from a reference.

Classification and anomaly-detection studyExplore paper

Formal concept structure constrains an interpretable logistic risk model.

Inspectable clinical-risk modelExplore paper

Sequence forecasts, risk-aware policy learning, and downside-risk control inform allocation.

Methodological research · not investment adviceExplore paper
Cold-start drug–target affinity. Scientific Reports, 2026. Drug and protein representations interact before simulated residual quantum paths return to classical fusion.

Choose a study. Explore how the method works.

Research you can inspect.

Three biomedical studies, from the research question to the evidence. Open a paper to explore its model and check a small reproduction.

All publications

Different data.
The same discipline.

Molecules, ECG beats, health indicators, and market sequences call for different models. I return to the same three questions: what structure should be represented, where could the method fail, and what evidence can a reader inspect?

A common path through each studyFour problem settings, mapped by the question each stage answers.
2025—2026
01

Drug–protein pairs

molecules · sequences
Represent
Graphs, fragments, fingerprints + language-model views
Stress-test
Unseen drug, target, or both
Examine
Fold effects + explicit evidence gaps
Output
Affinity estimate
Read study
02

ECG beats

morphology · timing
Represent
Morphology + angle–distance geometry
Stress-test
Repeated patient-level splits
Examine
Kernel components, ablations + anomaly scores
Output
Class / anomaly
Read study
03

Health indicators

survey-derived cohort
Represent
Formal concepts + constrained coefficients
Stress-test
Held-out discrimination + calibration
Examine
Linear weights + concept structure
Output
Risk estimate
Read study
04

Market sequences

forecast · downside risk
Represent
Sequence forecasts + downside objective
Stress-test
Regime, leakage, cost + backtest assumptions
Examine
Objective, protocol + stated limits
Output
Allocation
Read study
Shared standardThe model is one part of the evidence. Splits, baselines, limitations, and reproducible artifacts determine what a result can support.
Explore the research questions

Engineering beyond
the notebook.

From markerless posture research to Kinematum and KinemaCoach: a connected path through computer vision, model evaluation, and product engineering.

Full work experience

Feb 2026–present

Co-Founder & CTO

Kinematum

Tehran · Full-time

Leading technical development at an AI and biomechanics company focused on markerless posture and motion analysis. Translated six months of laboratory research into a production-facing posture-analysis platform powering KinemaCoach.

Research into product

KinemaCoach — AI-enabled posture assessment, motion analysis, and personalized movement guidance.

  1. Laboratory research

    Six months developing and evaluating markerless posture estimation.

  2. Kinematum platform

    Research translated into a production-facing posture-analysis platform.

  3. KinemaCoach

    The resulting technology powers an AI-enabled movement product.

Thinking out loud.

Notes on the decisions behind a model: its assumptions, its evaluation, and where it can fail.

All research notes

A researcher’s curiosity.
An engineer’s instincts.

My path started in computer engineering at Sharif University of Technology. Building production software taught me to care about what happens after an idea leaves the notebook.

Today, my research spans ECG signals, interpretable clinical-risk models, and drug–target affinity. I bring the same questions to each: what can we learn, how can we check it, and where does it stop working?

Good work starts
with a conversation.

Have a research question or a system worth building? Let’s talk.